Safar M E, Lévy B I
Institut de la Santé et de la Recherche Médicale, Unités 337 et 141, Hôpital Lariboisière, Paris, France.
Drugs. 1993;46 Suppl 2:68-74. doi: 10.2165/00003495-199300462-00013.
Alterations in the structure and function of large arteries could be a major factor in the mortality and morbidity of hypertensive patients. This paper summarises the effects of various pharmacological treatments on the mechanical (functional) properties of large arterial walls and on the structure and composition of these vessels. Firstly, during arterial hypertension, increases in arterial stiffness, associated with medial hypertrophy and/or hyperplasia and alterations in extracellular matrix, are always observed. Sodium intake and aging may influence the arterial wall properties, causing an increase in stiffness, independently of their effect on blood pressure. In parallel, administration of low doses of diuretics to hypertensive rats did not cause significant haemodynamic changes, but did cause an increase in arterial distensibility. Nitrates and derivatives have specific effects on the smooth muscle from large arteries in hypertensive patients. Significant increases in the diameter of large arteries and in arterial wall stiffness have been reported in clinical studies, but these effects have a short time constant. In humans and animals, angiotensin converting enzyme (ACE) inhibitors and calcium antagonists cause relaxation of arterial smooth muscle and, therefore, improve the functional component of the reduced distensibility observed in hypertension. Long term treatment with ACE inhibitors and calcium antagonists induces a significant reduction in medial hypertrophy. However, it is difficult to distinguish between the direct effects resulting from pressure reduction and a specific drug effect.
大动脉结构和功能的改变可能是高血压患者死亡率和发病率的主要因素。本文总结了各种药物治疗对大动脉壁力学(功能)特性以及这些血管结构和组成的影响。首先,在动脉高血压期间,总是会观察到动脉僵硬度增加,这与中层肥厚和/或增生以及细胞外基质改变有关。钠摄入和衰老可能会影响动脉壁特性,导致僵硬度增加,而与它们对血压的影响无关。同时,给高血压大鼠服用低剂量利尿剂不会引起显著的血流动力学变化,但会导致动脉扩张性增加。硝酸盐及其衍生物对高血压患者的大动脉平滑肌有特定作用。临床研究报告称,大动脉直径和动脉壁僵硬度显著增加,但这些作用的时间常数较短。在人和动物中,血管紧张素转换酶(ACE)抑制剂和钙拮抗剂可使动脉平滑肌松弛,因此可改善高血压患者观察到的扩张性降低的功能成分。长期使用ACE抑制剂和钙拮抗剂可使中层肥厚显著减轻。然而,很难区分降压产生的直接作用和特定药物作用。